Department of Internal Medicine, Division of Nephrology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Department of Internal Medicine, Division of Nephrology, Taoyuan Armed Forces General Hospital, Taoyuan, Taiwan.
Virulence. 2022 Dec;13(1):1349-1357. doi: 10.1080/21505594.2022.2107602.
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has become a global pandemic since December 2019. Most of the patients are mild or asymptomatic and recovered well as those suffered from other respiratory viruses. SARS-CoV-2 infection is supposed to demonstrate more sequelae. Acute kidney injury (AKI) is common among COVID-19 patients and is associated with disease severity and outcomes. Only a few studies focused on a detailed analysis of kidney damage in asymptomatic or mildly symptomatic COVID-19 patients. Whether any minor viral infection is likely to exhibit similar minor effect on renal function as COVID-19 is still unclear, and the definite pathophysiology of viral invasion is not fully understood. Currently, the proposed mechanisms of AKI include direct effects of virus on kidney, dysregulated immune response, or as a result of multi-organs failure have been proposed. This study will discuss the difference between COVID-19 and other viruses, focusing on proposed mechanisms, biomarkers and whether it matters with clinical significance.
新型冠状病毒病(COVID-19)是由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的,自 2019 年 12 月以来已成为全球大流行。大多数患者为轻症或无症状,并且像其他呼吸道病毒感染者一样恢复良好。SARS-CoV-2 感染可能会表现出更多的后遗症。急性肾损伤(AKI)在 COVID-19 患者中很常见,并且与疾病的严重程度和结果有关。只有少数研究集中在对无症状或症状轻微的 COVID-19 患者的肾脏损伤进行详细分析。任何轻微的病毒感染是否可能对肾功能产生类似的轻微影响,目前尚不清楚,病毒侵袭的确切病理生理学也不完全清楚。目前,提出的 AKI 发病机制包括病毒对肾脏的直接作用、失调的免疫反应或多器官衰竭的结果。本研究将讨论 COVID-19 与其他病毒的区别,重点讨论提出的机制、生物标志物以及与临床意义的关系。